首页 › 基金 › CAPITAL MANAGEMENT CORP /VA › HRMY

CAPITAL MANAGEMENT CORP /VA 对 HRMY 的持仓历史

HARMONY BIOSCIENCES HLDGS IN · 医疗保健

CAPITAL MANAGEMENT CORP /VA 在 Q3 2026 的 13F 申报中披露持有 HRMY(HARMONY BIOSCIENCES HLDGS IN)281,865 股,市值约 US$11.1M,约占其申报组合的 1.66%,在其申报持仓中市值排名第 29 位。 CAPITAL MANAGEMENT CORP /VA 最近 11 个申报季度中有 11 个季度披露了 HRMY 持仓,最早可追溯至 Q1 2024。

最新持仓 (Q3 2026)281.87K 股
申报持仓市值$11.07M
组合权重1.66%
首次申报Q1 2024
最近变动减持
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

CAPITAL MANAGEMENT CORP /VA 对 HRMY 的持仓演变

CAPITAL MANAGEMENT CORP /VA 于 Q1 2024 首次披露 HRMY 持仓:208,994 股(约 US$7.0M)。 该持仓在 Q4 2024 达到峰值 340,960 股,市值约 US$11.7M。 在 11 次申报中,CAPITAL MANAGEMENT CORP /VA 4 次增持、5 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 281,865 股、市值约 US$11.1M,环比减持 -3,635 股。。 持仓曾出现大幅变动:Q4 2024 增持约 43% (随后一个季度股价下跌 4%)。

逐季持仓明细

季度股数金额变化
Q1 2024 208.99K $7.02M 新进
Q2 2024 240.04K $7.24M 增持
Q3 2024 237.65K $9.51M 减持
Q4 2024 340.96K $11.73M 增持
Q1 2025 341.96K $11.35M 持有
Q2 2025 352.57K $11.14M 增持
Q3 2025 322.91K $8.90M 减持
Q4 2025 281.72K $10.54M 减持
Q1 2026 317.93K $8.91M 增持
Q2 2026 285.50K $10.40M 减持
Q3 2026 281.87K $11.07M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 HRMY 与 13F 数据

HRMY(HARMONY BIOSCIENCES HLDGS IN)属于医疗保健行业。我们追踪的基金中还有 38 只申报持有 HRMY,申报仓位最大的包括:ARMISTICE CAPITAL, LLC (US$56.9M), Valor Management LLC (US$29.8M), venBio Partners LLC (US$17.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 HRMY 的基金

查看 HRMY 的全部基金持有人 →

常见问题

How long has CAPITAL MANAGEMENT CORP /VA held HRMY?

CAPITAL MANAGEMENT CORP /VA has disclosed HRMY holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is CAPITAL MANAGEMENT CORP /VA's current position in HRMY?

As of Q3 2026, CAPITAL MANAGEMENT CORP /VA holds 281.87K shares of HRMY (HARMONY BIOSCIENCES HLDGS IN), valued at $11.07M, representing 1.66% of its reported portfolio and ranking #29.

Has CAPITAL MANAGEMENT CORP /VA been buying or selling HRMY?

In the latest 13F filing (Q3 2026), CAPITAL MANAGEMENT CORP /VA reduced its position in HRMY. The position peaked in Q4 2024 at 340.96K shares.

Which other funds hold HRMY?

Other major institutional holders of HRMY include ARMISTICE CAPITAL, LLC, Valor Management LLC, venBio Partners LLC, among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.